Duration of treatment. It is unusual for patients to take Naltrexone for more than 6 months. Initially patients should be reviewed weekly and after that every 28 days or at a frequency based on clinical judgement.
Duration of treatment. Medium to long term : depends on response to treatment, side effects and level of disease activity
Duration of treatment. For use after electrical cardioversion starting 4 weeks prior and continue for up to 12 months. Duration of treatment and review should be specified by cardiologist/specialist. For example 1. When PAF goes to permanent AF, amiodarone should be stopped and rate limiting medicines used instead. 2. Permanent AF/ Ventricular tachycardia- requires a 2 year prompt for consideration of stopping treatment 3. WPW- historic patients should be given opportunity to discuss treatment options Review regularly patients on long-term amiodarone treatment – some of these reactions may be life-threatening but onset can be delayed.
Duration of treatment. Indefinite but may be withdrawn after a prolonged period of disease remission in selected cases. It is also used as a rotational treatment in eczema.
Duration of treatment. 12-16 weeks Treatment Manuals or Protocol Descriptions: Xxxxxxx, X. X. (1997). Defiant children: A clinician’s manual for assessment and parent training. Guilford Press: New York. Xxxxxxxx, X. X., & XxXxxxx, X. X. (1981). Helping the noncompliant child: A clinician’s guide to parent training. Guilford Press: New York.
Duration of treatment. 6 sessions devoted to relationship enhancement; 6 sessions on disciplinary practices Treatment Manuals or Protocol Descriptions: Xxxxxxx-Xxxxx, X., & XxXxxx, X.X. (1995). Parent-Child Interaction Therapy. New York: Plenum. Xxxxxxx, X.X., Xxxxxx, X., XxXxxxx, X., & Xxxxxx, X. (1999). Parent-Child Interaction Therapy: Application to high-risk and maltreating families. Unpublished treatment manual. Author. Child Protection Center, Department of Pediatrics, University of California Xxxxx Medical Center, 0000 Xxxxxxxxx Xxxx., Xxxxxxxxxx, XX 00000 Xxxxxxx, X.X., Xxxxxx, X., XxXxxxx, X., & Xxxxxx, X. (1999). Parent-Child Interaction Therapy: Application to high-risk and maltreating families. Videotape series. Author. Child Protection Center, Department of Pediatrics, University of California Xxxxx Medical Center, 0000 Xxxxxxxxx Xxxx., Xxxxxxxxxx, XX 00000 Xxxxxxx, X.X., & XxXxxx, X.X. (1996). Parent-child interaction therapy: An intensive dyadic intervention for physically abusive families. Child Maltreatment, 1(2), 132-141. Treatment Outcome Study References: Xxxxxxx, X., & Xxxxxxx, X.X. (1998). Importance of therapist use of social reinforcement with parents as a model for parent-child relationships: An example with Parent-Child Interaction Therapy. Child and Family Behavior Therapy, 20(4), 27-54. Xxxxxxx, Xx., X., Xxxxxxx, X.X., Xxxxxxxxx, X.X., & Xxxxxx, N. (1999). Parent-Child Interaction Therapy with a Family at High-Risk for Physical Abuse. Child Maltreatment, 4(4), 331-342. Xxxxxx, X.X. (1988). Parent-child interaction therapy: Integration of traditional and behavioral concerns. Child and Family Behavior Therapy, 10, 33-46. Xxxxxx, X., & Xxxxxxxx, X.X. (1982). Parent-child interaction training: Effects on family functioning. Journal of Clinical Child Psychology, 11, 130-137. Classification Rating: 3 Physical Abuse-informed Family Therapy
Duration of treatment. Residential 90 days to 1 year (dependent upon client treatment needs) Day treatment 90-180 days (dependent upon client treatment needs) Outpatient 90-180 days (dependent upon client treatment needs) The following services will be provided to clients in residential treatment for both Adult and Adolescent Programs: Weekly clinical services will include but are not limited to: • Individual therapy • Individual phase sheet counseling • Encounter group • Gender group • Gender specific trauma group • Process group • Caseload group • Peer group • Boundaries group • Anger management Bi-Weekly clinical services will include but are not limited to: • Family therapy • Relapse prevention • NA/AA
Duration of treatment. Indefinite but may be withdrawn after a prolonged period of disease remission in selected cases. Surgery DMARD therapy should not routinely be stopped in the perioperative period, although individualised decisions should be made for high-risk procedures (BSR) on the advice of a consultant.
Duration of treatment. Medium to long term: depends on response to treatment, side effects and level of disease activity. Adverse effects Common side effects as per SPC Fever, Blood disorders ( including Heinz body anaemia, megaloblastic anaemia) Cough, Dizziness, Nausea, Headache, Tinnitus, Insomnia, Gastric distress, Arthralgia Pruritus, Rash, Stomatitis, Taste disturbances, Proteinuria, Yellow discoloration of skin, urine and other bodily fluid Because sulfasalazine causes crystalluria and kidney stone formation, adequate fluid intake should be ensured during treatment.
Duration of treatment. Indefinite but may be withdrawn after a prolonged period of disease remission in selected cases. It is also used as a rotational treatment in eczema. For rheumatoid diseases improvement may take 2 to 3 months to occur.
